Your browser doesn't support javascript.
loading
Development and validation of a novel defined mutation classifier based on Lasso logistic regression for predicting the overall survival of immune checkpoint inhibitor therapy in renal cell carcinoma.
Chen, Minyu; Li, Pengju; Yao, Haohua; Liu, Fei; Fu, Liangmin; Wang, Yinghan; Zhu, Jiangquan; Xu, Quanhui; Liang, Hui; Zhou, Yayun; Wang, Zhu; Deng, Qiong; Chen, Wei; Cao, Jiazheng; Chen, Xu; Luo, Junhang.
Afiliación
  • Chen M; Department of Urology, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Li P; Department of Urology, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Yao H; Institute of Precision Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Liu F; Department of Urology, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Fu L; Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Wang Y; Department of Urology, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Zhu J; Department of Urology, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Xu Q; Department of Urology, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Liang H; Department of Urology, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Zhou Y; Department of Urology, Affiliated Longhua People's Hospital, Southern Medical University, Shenzhen, China.
  • Wang Z; Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.
  • Deng Q; Department of Urology, Affiliated Longhua People's Hospital, Southern Medical University, Shenzhen, China.
  • Chen W; Department of Urology, Affiliated Longhua People's Hospital, Southern Medical University, Shenzhen, China.
  • Cao J; Department of Urology, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Chen X; Department of Urology, Jiangmen Central Hospital, Jiangmen, China.
  • Luo J; Department of Urology, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Transl Androl Urol ; 12(3): 406-424, 2023 Mar 31.
Article en En | MEDLINE | ID: mdl-37032757
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Transl Androl Urol Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Transl Androl Urol Año: 2023 Tipo del documento: Article